Keywords:
SARS-CoV-2; adults; non-pharmaceutical intervention; respiratory infection; respiratory syncytial virus; respiratory virus infection; seasonality
Abstract:
The incidence of respiratory syncytial virus (RSV) in adults is inadequately defined and the impact of SARS-CoV-2-related non-pharmaceutical interventions (NPIs) is underexplored. Using laboratory data, we described the detection rate of RSV in adults ≥16 years in Western Australia (WA) between 2017 and 2023.